Theraclion Sa Stock Performance
| TCLIF Stock | USD 0.0002 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Theraclion are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Theraclion SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Theraclion is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 2.3 M | |
| Total Cashflows From Investing Activities | -524.5 K | |
| Free Cash Flow | -4 M |
Theraclion |
Theraclion Relative Risk vs. Return Landscape
If you would invest 0.02 in Theraclion SA on September 28, 2025 and sell it today you would earn a total of 0.00 from holding Theraclion SA or generate 0.0% return on investment over 90 days. Theraclion SA is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Theraclion, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Theraclion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theraclion's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Theraclion SA, and traders can use it to determine the average amount a Theraclion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TCLIF |
Based on monthly moving average Theraclion is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theraclion by adding Theraclion to a well-diversified portfolio.
Theraclion Fundamentals Growth
Theraclion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Theraclion, and Theraclion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Theraclion Pink Sheet performance.
| Return On Asset | -0.25 | |||
| Operating Margin | (8.41) % | |||
| Current Valuation | 21.63 M | |||
| Shares Outstanding | 28.8 M | |||
| Price To Book | 54.78 X | |||
| Price To Sales | 88.51 X | |||
| Revenue | 1.48 M | |||
| EBITDA | (4.44 M) | |||
| Total Debt | 2.94 M | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (3.88 M) | |||
| Earnings Per Share | (0.30) X | |||
| Total Asset | 10.83 M | |||
About Theraclion Performance
By analyzing Theraclion's fundamental ratios, stakeholders can gain valuable insights into Theraclion's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Theraclion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Theraclion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. The company was incorporated in 2004 and is based in Malakoff, France. Theraclion operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 24 people.Things to note about Theraclion SA performance evaluation
Checking the ongoing alerts about Theraclion for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Theraclion SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Theraclion SA generated a negative expected return over the last 90 days | |
| Theraclion SA has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 1.48 M. Net Loss for the year was (3.76 M) with loss before overhead, payroll, taxes, and interest of (1.4 M). | |
| Theraclion generates negative cash flow from operations | |
| About 23.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Theraclion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Theraclion's stock is overvalued or undervalued compared to its peers.
- Examining Theraclion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Theraclion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Theraclion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Theraclion's pink sheet. These opinions can provide insight into Theraclion's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Theraclion Pink Sheet analysis
When running Theraclion's price analysis, check to measure Theraclion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theraclion is operating at the current time. Most of Theraclion's value examination focuses on studying past and present price action to predict the probability of Theraclion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theraclion's price. Additionally, you may evaluate how the addition of Theraclion to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |